CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: Results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies

P. V. O'Donnell, R. J. Jones, G. B. Vogelsang, A. Seber, R. F. Ambinder, I. Flinn, C. Miller, D. C. Marcellus, C. Griffin, R. Abrams, H. G. Braine, M. Grever, A. D. Hess, S. Piantadosi, S. J. Noga

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: Results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences